Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response

Author(s):  
1985 ◽  
Vol 31 (8) ◽  
pp. 1278-1282 ◽  
Author(s):  
S M Gordon ◽  
J P Szidon ◽  
B K Krotoszynski ◽  
R D Gibbons ◽  
H J O'Neill

Abstract Using a specially developed breath collection technique and computer-assisted gas chromatography/mass spectrometry (GC/MS), we have identified in the exhaled air of lung cancer patients several volatile organic compounds that appear to be associated with the disease. The GC/MS profiles of 12 samples from lung cancer patients and 17 control samples were analyzed by using general computerized statistical procedures to distinguish lung cancer patients from controls. The selected volatile compounds had sufficient diagnostic power in the GC/MS profiles to allow almost complete differentiation between the two groups in a limited patient population.


2020 ◽  
Vol 56 (12) ◽  
pp. 801-805
Author(s):  
Maria Ángeles Muñoz-Lucas ◽  
Javier Jareño-Esteban ◽  
Carlos Gutiérrez-Ortega ◽  
Pablo López-Guijarro ◽  
Luis Collado-Yurrita ◽  
...  

Metabolites ◽  
2020 ◽  
Vol 10 (8) ◽  
pp. 317
Author(s):  
Michalis Koureas ◽  
Paraskevi Kirgou ◽  
Grigoris Amoutzias ◽  
Christos Hadjichristodoulou ◽  
Konstantinos Gourgoulianis ◽  
...  

The aim of the present study was to investigate the ability of breath analysis to distinguish lung cancer (LC) patients from patients with other respiratory diseases and healthy people. The population sample consisted of 51 patients with confirmed LC, 38 patients with pathological computed tomography (CT) findings not diagnosed with LC, and 53 healthy controls. The concentrations of 19 volatile organic compounds (VOCs) were quantified in the exhaled breath of study participants by solid phase microextraction (SPME) of the VOCs and subsequent gas chromatography-mass spectrometry (GC-MS) analysis. Kruskal–Wallis and Mann–Whitney tests were used to identify significant differences between subgroups. Machine learning methods were used to determine the discriminant power of the method. Several compounds were found to differ significantly between LC patients and healthy controls. Strong associations were identified for 2-propanol, 1-propanol, toluene, ethylbenzene, and styrene (p-values < 0.001–0.006). These associations remained significant when ambient air concentrations were subtracted from breath concentrations. VOC levels were found to be affected by ambient air concentrations and a few by smoking status. The random forest machine learning algorithm achieved a correct classification of patients of 88.5% (area under the curve—AUC 0.94). However, none of the methods used achieved adequate discrimination between LC patients and patients with abnormal computed tomography (CT) findings. Biomarker sets, consisting mainly of the exogenous monoaromatic compounds and 1- and 2- propanol, adequately discriminated LC patients from healthy controls. The breath concentrations of these compounds may reflect the alterations in patient’s physiological and biochemical status and perhaps can be used as probes for the investigation of these statuses or normalization of patient-related factors in breath analysis.


Nanoscale ◽  
2019 ◽  
Vol 11 (5) ◽  
pp. 2476-2483 ◽  
Author(s):  
E. Kovalska ◽  
P. Lesongeur ◽  
B. T. Hogan ◽  
A. Baldycheva

Multilayer graphene can be used to detect volatile organic compounds, with enhanced selectivity and sensitivity through surface patterning.


2008 ◽  
Vol 861 (1) ◽  
pp. 101-107 ◽  
Author(s):  
J.J.B.N. Van Berkel ◽  
J.W. Dallinga ◽  
G.M. Möller ◽  
R.W.L. Godschalk ◽  
E. Moonen ◽  
...  

2015 ◽  
Vol 21 (8) ◽  
pp. 1776-1785 ◽  
Author(s):  
Alexander G. L. Bodelier ◽  
Agnieszka Smolinska ◽  
Agnieszka Baranska ◽  
Jan W. Dallinga ◽  
Zlatan Mujagic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document